APA (7th ed.) Citation

Donkeng-Donfack, V. F., Tchatchueng-Mbougua, J. B., Abanda, N. N., Ongboulal, S. M., Djieugoue, Y. J., Kamdem Simo, Y., . . . Eyangoh, S. (2022). A cost–benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns. BMC Infectious Diseases, 22(1), 1. https://doi.org/10.1186/s12879-022-07157-0

Chicago Style (17th ed.) Citation

Donkeng-Donfack, Valerie Flore, et al. "A Cost–benefit Algorithm for Rapid Diagnosis of Tuberculosis and Rifampicin Resistance Detection During Mass Screening Campaigns." BMC Infectious Diseases 22, no. 1 (2022): 1. https://doi.org/10.1186/s12879-022-07157-0.

MLA (9th ed.) Citation

Donkeng-Donfack, Valerie Flore, et al. "A Cost–benefit Algorithm for Rapid Diagnosis of Tuberculosis and Rifampicin Resistance Detection During Mass Screening Campaigns." BMC Infectious Diseases, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12879-022-07157-0.